Sector
PharmaceuticalsOpen
₹177.95Prev. Close
₹170.1Turnover(Lac.)
₹17.78Day's High
₹177.95Day's Low
₹172.152 Week's High
₹19952 Week's Low
₹74.5Book Value
₹30.22Face Value
₹10Mkt Cap (₹ Cr.)
111.39P/E
62.08EPS
2.74Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 6.44 | 6.44 | 6.44 | 6.44 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 11.28 | 9.16 | 6.73 | 3.35 |
Net Worth | 17.72 | 15.6 | 13.17 | 9.79 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 24.87 | 13.59 | 12.8 | 10.83 |
yoy growth (%) | 83.06 | 6.11 | 18.16 | -32 |
Raw materials | -9.91 | -4.85 | -4.8 | -3.94 |
As % of sales | 39.84 | 35.72 | 37.54 | 36.38 |
Employee costs | -2.53 | -2.41 | -2.25 | -2 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 4.04 | 1.84 | 1.05 | 0.83 |
Depreciation | -0.36 | -0.33 | -0.33 | -0.34 |
Tax paid | -0.65 | -0.2 | -0.02 | -0.03 |
Working capital | 1.48 | 2.04 | -0.55 | 0.24 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 83.06 | 6.11 | 18.16 | -32 |
Op profit growth | 79.81 | 49.87 | 12.03 | -23.81 |
EBIT growth | 106.34 | 65.14 | 16.47 | -28.8 |
Net profit growth | 105.76 | 59.76 | 28.15 | -42.97 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,665.2 | 130.91 | 3,99,537.26 | 867.6 | 0.81 | 5,536.99 | 98.75 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,205.6 | 35.29 | 1,21,311.57 | 1,405.2 | 0.25 | 3,172.6 | 156.19 |
Cipla Ltd CIPLA | 1,499.9 | 32.61 | 1,21,119.62 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Divis Laboratories Ltd DIVISLAB | 4,549.75 | 76.67 | 1,20,781.57 | 531 | 0.66 | 2,259 | 507.93 |
Dr Reddys Laboratories Ltd DRREDDY | 6,854.2 | 26.69 | 1,14,348.41 | 1,034.8 | 0.58 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
NARAYANAN NARASIMHAN
Managing Director
Arvind Varchaswi N
E D & Wholetime Director
Tejagna Kashmira Katpitia
Independent Director
Gowra Srinivas
Independent Director
CHANDRAKANT LAXMINARAYAN RATHI
Independent Director
Sriram Chandrasekaran
Independent Director
Bharathy
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Source Natural Foods & Herbal Supplements Ltd
Summary
Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995. The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12. The Company engages in the pharmaceutical business in India. It provides allopathic and ayurvedic formulations. Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets. Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country. Company focuses on such products which will bring Ayurveda in to individuals daily diet. It provide various Ayurvedic products in the form of medicines and herbal supplements. It focuses on ongoing R & D, which helps it to achieve its core objectives to bring more herbal and organic products in to the existing/ new product portfolio and to add more value to the existing products and develop organic food and nutritional supplements with an optimum mix of naturally available ingredients for attaining a sustainable improvement in the Health of all age Groups.In 2000, the Company hived-off the bulk drug unit and diversified into software related activities by changing the Main Clause. In 2001, it signed an agreement with CDSL, NSDL and Venture Capital and Corporate Investment for dematerialization. The factory, located at Hyderabad in Andhra Pradesh, was completely shut down since
Read More
The Source Natural Foods & Herbal Supplements Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹173.05 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Source Natural Foods & Herbal Supplements Ltd is ₹111.39 Cr. as of 26 Jul ‘24
The PE and PB ratios of Source Natural Foods & Herbal Supplements Ltd is 62.08 and 5.63 as of 26 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Source Natural Foods & Herbal Supplements Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Source Natural Foods & Herbal Supplements Ltd is ₹74.5 and ₹199 as of 26 Jul ‘24
Source Natural Foods & Herbal Supplements Ltd's CAGR for 5 Years at 18.11%, 3 Years at 3.73%, 1 Year at 85.90%, 6 Month at 82.90%, 3 Month at 93.36% and 1 Month at 47.58%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.